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ABSTRACT
Objective: To identify the occurrence of potential drug interactions in 
prescriptions for adult patients admitted to the Emergency Department 
of Hospital São Paulo. Methods: A cross-sectional and descriptive 
study. Its sample consisted of 200 medical prescriptions. The analysis 
of drug interactions was performed using the Drugs.com database, 
where they are classified according to severity of interaction as 
severe, moderate, mild and without interaction. Results: The number 
of drugs in prescriptions ranged from 2 to 19, and the average per 
prescription was 4.97 drugs. A total of 526 potential drug interactions 
were identified in 159 prescriptions (79.5%); in that, 109 were severe, 
354 moderate, 63 mild interactions, and 41 showed no interaction. 
Conclusion: This study demonstrated potential drug interactions 
in 79.5% of prescriptions examined in the Emergency Department. 
Drug interactions can occur at any time when using medications and, 
during this working process, the nursing staff is involved in several 
steps. Therefore, training the nursing staff for the rational use of drugs 
can increase safety of care delivered to patients.
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RESUMO 
Objetivo: Identificar a ocorrência de potenciais interações medicamentosas 
em prescrições médicas de pacientes adultos internados no Serviço 
de Emergência do Hospital São Paulo. Métodos: Estudo de corte 
transversal e descritivo. A amostra foi composta por 200 prescrições 
médicas. A análise das interações medicamentosas foi realizada por 
meio da base de dados Drugs.com, onde são classificadas quanto à 
potencialidade de ação em interação grave, moderada, leve e sem 
interação. Resultados: O número de medicamentos das prescrições 
variou de 2 a 19, e a média por prescrição foi de 4,97 medicamentos. 
Foram identificadas 526 potenciais interações medicamentosas em 
159 prescrições (79,5%); destas, 109 foram interações graves, 354 
moderadas, 63 leves e 41 não apresentaram interação. Conclusão: 
Este estudo demonstrou potencial interação medicamentosa em 
79,5% das prescrições analisadas no Serviço de Emergência. 
As interações medicamentosas podem acontecer em todos os 
momentos da utilização dos fármacos e, nesse processo de trabalho, 
a equipe de enfermagem está envolvida em diversas etapas. Portanto, 
instrumentalizar o enfermeiro para o uso racional dos fármacos pode 
aumentar a segurança da assistência ao paciente.
Descritores: Interações de medicamentos; Incompatibilidade de 
medicamentos; Segurança do paciente
INTRODUCTION
The last decades have witnessed an association between 
overcrowded emergency services and a decrease in the 
quality of care(1). 
In addition to overcrowding, other factors such as 
stress, insufficient number of healthcare professionals, 
high turnover of patients, and communication failure 
among multiprofessional teams turn emergency services 
into a critical site for the occurrence of problems(2). 
Some errors are associated with the use of medication: 
drug interactions, adverse events, allergic reactions, 
and medication errors(3). The most frequently reported 
errors in emergency departments are associated with 
drug-related adverse events(4). 
Medical treatment is essential in healthcare. 
Yet, it may cause disease and death, and become an 
economic burden to society(3). Despite the fact that the 
simultaneous use of several drugs frequently increases 
their therapeutic efficacy, certain combinations are 
harmful and may increase the risk of drug interaction(5). 
In emergency departments, often several drugs 
are prescribed simultaneously. This may cause non-
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therapeutic interaction in a patient and eventually harm 
the patient(6).
Drug interaction is a pharmacological response 
where the effect of one or more drugs is changed 
by their simultaneous administration, or by previous 
use of other drugs(5). Drug interactions depend on a 
number of variables, such as clinical condition of the 
patient, number and characteristics of drugs, and are 
aggravated by the fact that health professionals are 
unaware of the actions of these medicines. The nurses 
are in charge of preparing prescriptions, and many 
times potential interactions are disregarded(7). Drug 
interaction is one of the most important variables in 
the treatment, and its clinical significance is difficult 
to predict(8).
The clinical pharmacists play several roles in medical 
therapy, such as revising prescriptions to investigate 
drug interactions and writing recommendations, which 
must contribute to patient´s safety(9).
In emergency departments, nurses and all members 
of the multiprofessional team must offer immediate 
care to critical patients, and use their clinical judgement 
regarding the use of prescribed drugs, in order to avoid 
possible drug interaction or decreased efficacy in the 
treatment proposed(7). 
OBJECTIVE
To identify the occurrence of potential drug interactions 
in prescriptions for adult patients admitted to the 
Emergency Department of Hospital São Paulo. 
METHODS
This article describes a cross-sectional study carried 
out at Hospital São Paulo. The convenience sample 
consisted of all medical prescriptions within the first 
24 hours of adult patients admitted to the Clinical 
Emergency Room of the Emergency Department, from 
March to July 2012. 
Data collection consisted in transcribing all pieces 
of information to individual patient files. The following 
variables were recorded: date of admission, gender, 
age, past medical/surgical history, name of the drug, 
dosage, pharmaceutical formulation and route of 
administration. 
The analysis of drug interaction was performed 
using the database Drugs.com. In the database, all 
drugs in the prescription were matched and a list with 
the drug interactions was obtained, classifying them as 
to severity as severe, moderate, and mild interaction, 
and no interaction(10).
Data was analyzed by means of descriptive statistics 
and presented as graphs and tables. 
The study was conducted after the analysis and 
approval by the Research Ethics Committee of Universidade 
Federal de São Paulo (CAAE: 00849512.6.0000.5505).
RESULTS
The sample comprised 200 medical prescriptions, and 
53.5% (n=103) of them had been prescribed to women 
with mean age of 51.3 years. 
The most frequent conditions described in patients´ 
past history were cardiovascular (66%) and endocrine 
(25%) disorders. 
The number of drugs listed in the prescriptions 
varied from 2 to 19; in average, 4.97 drugs were listed per 
prescription. A total of 779 drugs had been prescribed. 
Metoclopramide (28.1%), sodium dipyrone (15.0%), 
tramadol hydrochloride (10.0%), omeprazole (9.5%), 
phenytoin (8.0%) and clarithromycin (7.4%) were the 
most frequently prescribed drugs. 
The analyses carried out using the database Drugs.
com identified 526 potential drug interactions in 
159 prescriptions (79.5%); in that, 109 (21%) were 
severe; 354 (67%) moderate; 63 (12%) mild interactions; 
and 41 prescriptions had no drug interaction (Figure 1). 
Table 1 lists the drug interactions classified as severe 
according to the database Drugs.com. 
Table 2 lists the drug interactions classified as 
moderate according to the database Drugs.com. 
 Table 3 lists drug interactions that were considered 
mild according to the database Drugs.com. 
Figure 1. Potential drug interactions in the prescriptions of patients admitted to 
the Clinical Emergency Service of Hospital São Paulo, between March and July, 
São Paulo, 2012
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DISCUSSION
This study points out the need to assess possible drug 
interactions in prescriptions made in the Emergency 
Services. The risk associated with drug interactions 
was shown by the number of potential severe and 
moderate drug interactions identified in prescriptions 
written during the first 24 hours of admission to the 
service. 
In this study, the mean age of patients was 51.3 
years. This result is similar to that of the study carried 
out at the Intensive Care Unit (ICU), in which the mean 
age of patients was 56.3(11).
Most frequently reported conditions were cardiovascular 
diseases (66%) and diabetes mellitus (25%). These 
results are also in line with the findings of another 
study that described the prevalence of potential 
drug interactions in clinical and surgical units where 
cardiovascular (42,5%) and endocrine diseases (20.8%) 
were most frequently observed(12). Further studies on 
this subject are required, due to the limited number 
of investigations on presence of comorbidities and 
potential risks of drug interactions. This study showed a 
high prevalence of potential drug interactions (79.5%) 
among the drugs found in the prescriptions. This is 
corroborated by the findings of another study carried 
out in ICU (67.1%), which was used to compare 
data because there is a lack of studies in the area of 
emergency services(13). 
The number of drugs listed in the prescriptions 
varied between 2 and 19, and the mean number of drugs 
per prescription was 4.97. Another study that evaluated 
potential drug interactions in prescriptions for patients in 
Intensive Care Units (ICUs) and Rooming-in identified 
a larger number of drugs (5 to 22), with an average of 
10.9 drugs per prescription(14). 
Assessments carried out using the database Drugs.
com, showed a high prevalence of interactions at the 
Emergency Department. Out of these, 109 were severe, 
354 moderate and 63 mild cases. These results are 
greater than those of another study that identified 38 
prescriptions for patients at the ICU – in that, 105 were 
severe, 171 moderate and 18 mild(14) interactions. 
Most commonly prescribed drugs associated with 
moderate and mild interactions were phenytoin, 
omeprazole, captopril, sodium heparin, clarithromycin 
and sodium dipyrone. These interactions may worsen 
the clinical condition of the patient, require additional 
treatment, increase the hospital length of stay, or cause 
discomfort. These results are consistent with another 
study, which also found out that dipyrone sodium, 
captopril and sodium heparin were the drugs most 
commonly involved in drug interactions(13). 
Table 1. Frequency of severe drug interactions identified in the prescriptions 
of patients admitted to the Clinical Emergency Service of Hospital São Paulo, 
between March and July, São Paulo, 2012 
 Drug I Drug II n Frequency (%)
Metoclopramide Tramadol 33 30.4
Sodium dipyrone Enoxaparin sodium 13 11.9
Warfarin Enoxaparin sodium 11 10.2
Amiodarone Clarithromycin 6 5.6
Tramadol Meropenem 5 4.6
Ciprofloxacin Tramadol 3 2.7
Haloperidol Fluconazole 3 2.7
Haloperidol Metoclopramide 3 2.7
Morphine Tramadol 3 2.7
Amiodarone Furosemide 2 1.8
Amiodarone Haloperidol 2 1.8
Acetylsalicylic acid Enoxaparin sodium 2 1.8
Warfarin Clarithromycin 2 1.8
Other* Other 21 19.3
Total  109 100
  *Frequencies <1.8% were included under the category others.  
Table 2. Frequency of moderate drug interactions identified in the prescriptions 
of patients admitted to the Clinical Emergency Service of Hospital São Paulo, 
between March and July, São Paulo, 2012
Drug I Drug II n Frequency (%)
Phenytoin Omeprazole 24 6.8
Captopril Heparin 14 3.9
Captopril Enoxaparin sodium 8 2.3
Warfarin Tramadol 8 2.3
Other* Other 300 84.7
 Total 354 100
*Frequencies <1.8% were included in the category others.
Table 3. Frequency of mild drug interactions identified in the prescriptions of 
patients admitted to the Clinical Emergency Service of Hospital São Paulo, 
between March and July, São Paulo, 2012 
Drug I Drug II n Frequency (%)
Clarithromycin Omeprazole 7 11.1
Dipyrone Sodium Heparin 5 7.9
Ceftriaxone Sodium Heparin 5 7.9
Acetylsalicylic acid Omeprazole 4 6.3
Oxacillin Heparin 4 6.3
Rifampicin Midazolam 4 6.3
Ciprofloxacin Metoclopramide 3 4.8
Metoclopramide Morphine 3 4.8
Enalapril Amlopidine 2 3.2
Furosemide Acetylsalicylic acid 2 3.2
Nifedipine Omeprazole 2 3.2
Levothyroxine Simvastatin 2 3.2
Ranitidine Ketoprofen 2 3.2
Others* Others 18 28.6
 Total 63 100
*Frequencies <1.8% were included in the category others. 
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Interaction between tramadol and metoclopramide 
was the most frequent (30.27%) among severe drug 
interactions. Similar information was reported in 
another study where 60% of drug interactions included 
these two drugs(14). The assessment carried out on the 
database Drugs.com reveals that this combination is 
highly lethal, and depending on the dose may cause 
death of the patient(10). 
The risk of seizures increases when tramadol is 
simultaneously administered with other medications, 
such as selective serotonin reuptake inhibitors, amino-
oxidase inhibitors, neuroleptic agents that stimulate 
the nervous system, opioids, among others. When 
administered alone, these agents are often epileptogenic 
and may have potentiated effects when given in 
combination with other drugs(10). 
In addition to interaction with metoclopramide, 
tramadol presented potential interaction with other 
drugs, such as antibacterial agents and drugs that act 
on the central nervous system, such as amitriptyline, 
fluoxetine and morphine(14).
In the case of moderate interactions, the combined 
use of omeprazole and phenytoin was the most 
frequent (10.6%) and, despite their different indications, 
these medications have antagonistic effects. Similar 
information was reported in a study that evidenced this 
interaction in 29.3% of findings(15). 
Omeprazole may increase the serum concentration 
of phenytoin and thus its toxicity, inhibiting liver 
metabolism and drug excretion. Furthermore it can 
interact in a similar fashion with other hydantoins. This 
medication is more susceptible to potential interactions 
when given at doses >40mg/day(16). In addition to laboratory 
follow-up to assess the side effects of phenytoin, the 
combined use of these medications requires observation 
of signs and symptoms that indicate toxicity: sleepiness, 
visual impairment, changes in metal status, seizures, 
nausea and ataxia(10).
Mild interactions do not present significant clinical 
value because they do not potentially alter the effects 
of the drugs(14). Out of the 63 mild interactions, 11.1% 
were associated with the use of omeprazole and 
clarithromycin. A similar result was described in a 
study on factors associated with medical prescription 
of antibiotics in public pharmacies, which presented 
16.6% of this type of interaction(17).
Clarithromycin may increase and extend the serum 
concentration of omeprazole in the body. This may be 
associated with the fact that clarithromycin inhibits 
cytochrome in liver enzymes, which are involved in 
omeprazole metabolism. Combined administration 
of omeprazole may also cause an increase in serum 
clarithromycin concentration. This increase could be 
associated with the effect of omeprazole on gastric 
pH(10).
Another important concern is the presence of more 
than one drug interaction on the same prescription. 
Drug interactions must be investigated in these cases, 
even in the absence of immediate clinical investigation, 
because an early suspicion would enable the health 
team to prepare for possible pharmacodynamic or 
pharmacokinetic adverse reactions(18).
CONCLUSIONS
This study demonstrated potential drug interaction in 
the majority of prescriptions assessed in the Clinical 
Emergency Sector of Hospital São Paulo. Due to the 
characteristics of emergency services, a number of 
strategies should be implemented to increase patient 
safety. 
Further studies must be conducted to cover all 
phases of drug use, and include the design of protocols 
to ensure greater safety in the use of drugs in these units. 
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